1Parsons CL, BuUen M, Kahn BS, et al. The gynecological presentation of intersitital cystitis as detected by intravesical potassium sensitivity. Obstet Gynecol, 2001, 98:127-132.
2Nickel JC, Barkin J, Forrest J, et al. Randomized, double-blind,dose-ranging study of pentosan polysulfate sodium (PPS) for interstitial cystitis (IC). J Urol, 2001, 165 (5 Suppl): 67.
3Hohlbrugger G. Urinary potassium and overastive bladder. BJU Int,1999, 83:22.
4Gregoire M, Liandier F, Vaud A, et al. Does the potassium stimulation test predict cystometric, cystoscopic outcome in interstitial cystitis. J Urol, 2002, 168:556-557.
5Mold RM, Sant GR. Interstitial cystitis: a pathophysiology and treatment update. Clin Obstet Gynecol, 2002, 45:259-272.
6Boucher WS, Leturneau R, Huang M,et al. Intravelical sodium hyaluronate inhibits the rat urinary most cell mediator increase triggered by acute immobilization stress. J Urol, 2002, 167:380-384.
7Keay S, Kleinberg M, Zhang CO, et al. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparinbinding epidermal growth factor-like growth factor production. J Urol,2000, 164:2112.
8Sun Y, Keay S, Deyne PC,, et al. Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol, 2001, 166:1951-1956.
9Lutgendorf SIL Kreder KJ, Rothrock NE, et al. Diurnal cortisol variations and symptoms in patients with interstitial cystitis. J Urol,2002, 167:1338-1343.
10Sant GR. Etiology, Pathogenesis and diagnosis of interstitial cystitis.Rev Urol, 2002, 4(sapplyl):Sg-S15.
